Table 3 Early Clinical Progress (*Δ-NIHSS) and SUA levels (μmol/L) in the three population subgroups
From: Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study
Δ-NIHSS (± SD) | ||||||
|---|---|---|---|---|---|---|
SUA levels | All | < 305 | 305-399 | ≥ 400 | p | |
rt-PA group | 3.62 (± 6.3) | 3.0 (± 6.2) | 2.2 (± 6.6) | 5.2 (± 5.9) | < 0.01 | |
Early, no rt-PA | 1.2 (± 4.0) | 1.4 (± 3.8) | 0.8 (± 4.2) | 1.3 (± 4.6) | 0.2 | |
Late group | 1.0 (± 3.7) | 1.3 (± 3.1) | 0.9 (± 5.2) | 1.0 (± 4.4) | 0.3 | |